Latest Medical Press Releases
Leverage your last mile – Is Mark Cuban a partner for the independent pharmacy?
Why would a patient pay $8 for same-day delivery through a digital pharmacy startup? There is no other business model
27/10/2023
Rainbird Announces Partnership with Relanto to Combine Explainable AI and Human-Centric Business Transformation
NORWICH, UK 18th April 2023 – Rainbird Technologies has formed a strategic partnership with Relanto, a global consulting and professional
27/10/2023
Excivion announces results of an international collaboration evaluating the utility of its novel point-of-care dengue and Zika antibody tests
CAMBRIDGE UK – Excivion Ltd (www.excivion.com), a biotechnology company developing novel vaccines based on its proprietary glycan-cloaking molecular design and
27/10/2023
PharmiWeb Launches New US-Focused Life Science Job Board
Berkshire, UK. 11th October 2021. PharmiWeb.jobs, Europe’s largest dedicated Life Science Job Board, has today launched a new US-focused version
27/10/2023
Revax Biotech Ultra-Low Dose Vaccine Technology can make World Vaccination a Reality
Revax Biotech announce their response to the G7/WHO Challenge enabling vaccines to be available to meet existing or emerging respiratory
27/10/2023
PharmiWeb Launches New US-Focused Life Science Job Board
Berkshire, UK. 11th October 2021. PharmiWeb.jobs, Europe’s largest dedicated Life Science Job Board, has today launched a new US-focused version
27/10/2023
Aleva Neurotherapeutics SA Announces MRI Approval for its directSTIM™ Deep Brain Stimulation System
Lausanne, Switzerland, 14 September 2022 – Aleva Neurotherapeutics SA, the company that pioneered Directional Deep Brain Stimulation (DBS) in Neuromodulation,
27/10/2023
Massive Bio Publishes the Second Issue of Massive Bio magazine
November 2nd, 2022: Massive Bio, a leader in AI-powered cancer clinical trial enrollment, has published the second issue of Massive
27/10/2023
Esya Labs Awarded $452,000 Grant from the Michael J. Fox Foundation (MJFF) to Develop Peripheral Biomarkers for Parkinson’s Disease
London, UK, November 4th, 2022 – Esya Labs, a startup dedicated to developing early-stage biomarkers for neurodegenerative diseases, has been
27/10/2023